97 related articles for article (PubMed ID: 26474968)
41. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.
Shao LL; Zhang L; Hou Y; Yu S; Liu XG; Huang XY; Sun YX; Tian T; He N; Ma DX; Peng J; Hou M
PLoS One; 2012; 7(12):e51339. PubMed ID: 23236476
[TBL] [Abstract][Full Text] [Related]
42. Th22 cells are associated with hepatocellular carcinoma development and progression.
Qin S; Ma S; Huang X; Lu D; Zhou Y; Jiang H
Chin J Cancer Res; 2014 Apr; 26(2):135-41. PubMed ID: 24826053
[TBL] [Abstract][Full Text] [Related]
43. A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease.
Peng D; Xu B; Wang Y; Guo H; Jiang Y
PLoS One; 2013; 8(7):e68446. PubMed ID: 23874630
[TBL] [Abstract][Full Text] [Related]
44. CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.
Gu-Trantien C; Loi S; Garaud S; Equeter C; Libin M; de Wind A; Ravoet M; Le Buanec H; Sibille C; Manfouo-Foutsop G; Veys I; Haibe-Kains B; Singhal SK; Michiels S; Rothé F; Salgado R; Duvillier H; Ignatiadis M; Desmedt C; Bron D; Larsimont D; Piccart M; Sotiriou C; Willard-Gallo K
J Clin Invest; 2013 Jul; 123(7):2873-92. PubMed ID: 23778140
[TBL] [Abstract][Full Text] [Related]
45. IL-22 is related to development of human colon cancer by activation of STAT3.
Jiang R; Wang H; Deng L; Hou J; Shi R; Yao M; Gao Y; Yao A; Wang X; Yu L; Sun B
BMC Cancer; 2013 Feb; 13():59. PubMed ID: 23379788
[TBL] [Abstract][Full Text] [Related]
46. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
Huang Y; Zhang J; Cui ZM; Zhao J; Zheng Y
Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
[TBL] [Abstract][Full Text] [Related]
47. Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer.
Hou F; Li Z; Ma D; Zhang W; Zhang Y; Zhang T; Kong B; Cui B
Clin Chim Acta; 2012 Nov; 413(23-24):1848-54. PubMed ID: 22820395
[TBL] [Abstract][Full Text] [Related]
48. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer.
Liu T; Peng L; Yu P; Zhao Y; Shi Y; Mao X; Chen W; Cheng P; Wang T; Chen N; Zhang J; Liu X; Li N; Guo G; Tong W; Zhuang Y; Zou Q
J Clin Immunol; 2012 Dec; 32(6):1332-9. PubMed ID: 22760549
[TBL] [Abstract][Full Text] [Related]
49. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival.
Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Guo G; Chen W; Liu XF; Zhang JY; Liu T; Luo P; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):1965-75. PubMed ID: 22527243
[TBL] [Abstract][Full Text] [Related]
50. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis.
Zhang L; Li YG; Li YH; Qi L; Liu XG; Yuan CZ; Hu NW; Ma DX; Li ZF; Yang Q; Li W; Li JM
PLoS One; 2012; 7(4):e31000. PubMed ID: 22485125
[TBL] [Abstract][Full Text] [Related]
51. Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression.
Kosmaczewska A; Bocko D; Ciszak L; Wlodarska-Polinska I; Kornafel J; Szteblich A; Masternak A; Frydecka I
Pathol Oncol Res; 2012 Apr; 18(2):479-89. PubMed ID: 22094905
[TBL] [Abstract][Full Text] [Related]
52. Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease.
Ryan-Payseur B; Ali Z; Huang D; Chen CY; Yan L; Wang RC; Collins WE; Wang Y; Chen ZW
J Infect Dis; 2011 Nov; 204(9):1450-62. PubMed ID: 21921207
[TBL] [Abstract][Full Text] [Related]
53. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.
Sonnenberg GF; Fouser LA; Artis D
Nat Immunol; 2011 May; 12(5):383-90. PubMed ID: 21502992
[TBL] [Abstract][Full Text] [Related]
54. Recent advances in IL-22 biology.
Zenewicz LA; Flavell RA
Int Immunol; 2011 Mar; 23(3):159-63. PubMed ID: 21393631
[TBL] [Abstract][Full Text] [Related]
55. The imbalance of Th17/Treg in patients with uterine cervical cancer.
Zhang Y; Ma D; Zhang Y; Tian Y; Wang X; Qiao Y; Cui B
Clin Chim Acta; 2011 May; 412(11-12):894-900. PubMed ID: 21255562
[TBL] [Abstract][Full Text] [Related]
56. Regulation and functions of the IL-10 family of cytokines in inflammation and disease.
Ouyang W; Rutz S; Crellin NK; Valdez PA; Hymowitz SG
Annu Rev Immunol; 2011; 29():71-109. PubMed ID: 21166540
[TBL] [Abstract][Full Text] [Related]
57. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces.
Sonnenberg GF; Fouser LA; Artis D
Adv Immunol; 2010; 107():1-29. PubMed ID: 21034969
[TBL] [Abstract][Full Text] [Related]
58. Immunity, inflammation, and cancer.
Grivennikov SI; Greten FR; Karin M
Cell; 2010 Mar; 140(6):883-99. PubMed ID: 20303878
[TBL] [Abstract][Full Text] [Related]
59. Biology of interleukin-22.
Wolk K; Witte E; Witte K; Warszawska K; Sabat R
Semin Immunopathol; 2010 Mar; 32(1):17-31. PubMed ID: 20127093
[TBL] [Abstract][Full Text] [Related]
60. Circulating Th17, Th22, and Th1 cells are increased in psoriasis.
Kagami S; Rizzo HL; Lee JJ; Koguchi Y; Blauvelt A
J Invest Dermatol; 2010 May; 130(5):1373-83. PubMed ID: 20032993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
